Contineum Therapeutics Inc (NAS:CTNM)
$ 13.83 +0.13 (+0.91%) Market Cap: 520.30 Mil Enterprise Value: 290.89 Mil PE Ratio: 0 PB Ratio: 2.17 GF Score: 17/100

Contineum Therapeutics, Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 15, 2026 / 09:35 PM GMT
Release Date Price: $13.84 (-6.61%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CTNM.OQ - Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. at Morgan Stanley Global Healthcare Conference
Sep 15, 2026 / 09:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. My name is Sean Larman. I'm the Head of US MidCap Biotech Equity Research at Morgan Stanley and welcome to Morgan Stanley's Global Healthcare Conference. Before we begin, just to make you aware of some important disclosures, please see those disclosures at the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures.

And if you do have any questions on that, please reach out to your Morgan Stanley sales representative.

For this session, we welcome Continuum Therapeutics with CEO, Carmine Stangioni. Welcome, Carmine. I hope I pronounced your surname correctly.

Maybe just to begin. Start up with some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot